sclerosis/illamående

Länken sparas på Urklipp

Välj sorteringstyp

Sida 1 från 357 resultat

Nausea, vomiting and diarrhea: an unusual presentation of multiple sclerosis.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The case of a young woman who presented with nausea, vomiting and diarrhea is outlined; the etiology turned out to be a first attack of multiple sclerosis. Plausible mechanisms are discussed.

The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present paper describes the historical use of cannabis, starting with its use in Assyria and China. Recent advances in the understanding of the molecular basis of cannabis action are explained, including the identification of the cannabinoid receptors CB(1) and CB(2), as well as the isolation of

Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Interferon beta-1a is an established therapy for patients with relapsing-remitting multiple sclerosis (MS). Adverse effects in the first weeks of treatment are common. This open-label, multicenter, randomized, prospective study compared treatment of flu-like symptoms (FLS) with paracetamol versus

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated inflammatory non-malignant processes such as lupus nephritis and immune-mediated neuropathies. It has been studied as a treatment for multiple sclerosis (MS) for the past 30 years and is used by physicians in

The safety profile of cyclophosphamide in multiple sclerosis therapy.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Cyclophosphamide (Cyc) is an alkylating agent used to treat malignancies and autoimmune diseases, such as lupus nephritis, rheumatoid arthritis and immune-mediated neuropathies. Over the past 40 years, Cyc has also been applied to treat multiple sclerosis (MS) and the effective stabilisation of

Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Background: Mitoxantrone (MTX) has been used as an effective disease modifying treatment (DMT) in multiple sclerosis (MS). Evidence from studies demonstrates benefits of reduced relapse rates, MRI disease activity and disability

Off-label use of aprepitant for scleroderma-associated nausea and vomiting: A case report.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Scleroderma is a disease characterized by excessive deposition of collagen and extracellular matrix proteins in affected organ systems, which results in tissue fibrosis and organ dysfunction. It is estimated that 90% of patients with systemic sclerosis have gastrointestinal

Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND Calcitonin gene-related peptide (CGRP) is a vasodilatory neuropeptide that plays an important role in the blood vessels of heart and peripheral circulation, a lack of which may cause vasculopathies. OBJECTIVE In this study, the clinical course of disease, as well as the efficacy, side

Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

One hundred sixty-four patients with chronic progressive multiple sclerosis (MS) have been treated with a regimen of high-dose IV cyclophosphamide and ACTH over the past 6 years. Their status was reviewed to determine complications associated with treatment, dosage of medication used to induce a

Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

INTRODUCTION

We present a case of meningitis caused by Cryptococcus neoformans var. grubii in a 46-year old non-HIV-infected patient with multiple sclerosis, treated with dimethyl fumarate monotherapy. We identified no other risk factors for developing cryptococcal meningitis.

Multiple sclerosis as a cause of the acute vestibular syndrome.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Multiple sclerosis (MS) causes dizziness and vertigo. Reports suggest responsible lesions are often in the intra-pontine 8th nerve fascicle. We sought to determine frequency and clinical features of demyelinating acute vestibular syndrome (AVS). This is a prospective observational study (1999-2011).

Low-dose intravenous cyclophosphamide in systemic sclerosis: a preliminary safety study.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Both oral and intravenous high-dose cyclophosphamide (CYC) regimens are associated with serious side effects when used for the treatment of systemic sclerosis (SSc). The aim of the present trial was to test the safety of low-dose intravenous CYC in patients with SSc. Eight SSc patients, in whom CYC

Acute respiratory failure with gross hemoptysis in a patient with lymphangioleiomyomatosis as part of tuberous sclerosis complex.

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

A 29-year-old woman was admitted to our hospital with a 7-day history of elevated temperature to 39.5 degrees C associated with headache and nausea. She had been diagnosed with tuberous sclerosis complex 10 years earlier. Her unconsciousness progressed, and she was diagnosed as having aseptic

Tidigare
1
2
3
4
5
6
...
23
24
Nästa

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning